These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29106832)

  • 1. [Diabetes Mellitus, a prothrombotic disease].
    Picard F; Adjedj J; Varenne O
    Ann Cardiol Angeiol (Paris); 2017 Dec; 66(6):385-392. PubMed ID: 29106832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia: a prothrombotic factor?
    Lemkes BA; Hermanides J; Devries JH; Holleman F; Meijers JC; Hoekstra JB
    J Thromb Haemost; 2010 Aug; 8(8):1663-9. PubMed ID: 20492456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus.
    Soma P; Pretorius E
    Cardiovasc Diabetol; 2015 Jul; 14():96. PubMed ID: 26228646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic changes in diabetes mellitus.
    Morel O; Jesel L; Abbas M; Morel N
    Semin Thromb Hemost; 2013 Jul; 39(5):477-88. PubMed ID: 23629823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].
    Mafrici A; Proietti R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):467-77. PubMed ID: 20922872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet abnormalities in type 2 diabetes mellitus].
    Matadamas-Zárate C; Hernández-Jerónimo J; Pérez-Campos E; Majluf-Cruz A
    Arch Cardiol Mex; 2009 Dec; 79 Suppl 2():102-8. PubMed ID: 20361492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis.
    Morel O; Kessler L; Ohlmann P; Bareiss P
    Atherosclerosis; 2010 Oct; 212(2):367-76. PubMed ID: 20394927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical marker of platelet hyperreactivity in diabetes mellitus.
    Kim JH; Bae HY; Kim SY
    Diabetes Metab J; 2013 Dec; 37(6):423-8. PubMed ID: 24404513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection.
    Otamas A; Grant PJ; Ajjan RA
    Diab Vasc Dis Res; 2020; 17(3):1479164120920582. PubMed ID: 32506946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes Mellitus.
    Yahagi K; Kolodgie FD; Lutter C; Mori H; Romero ME; Finn AV; Virmani R
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):191-204. PubMed ID: 27908890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus and thrombosis.
    Vazzana N; Ranalli P; Cuccurullo C; Davì G
    Thromb Res; 2012 Mar; 129(3):371-7. PubMed ID: 22197180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets and Antiplatelet Therapy in Patients with Coronary Artery Disease and Diabetes.
    Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL
    Semin Thromb Hemost; 2016 Apr; 42(3):234-41. PubMed ID: 26886397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet abnormalities in diabetes mellitus.
    Ferreiro JL; Gómez-Hospital JA; Angiolillo DJ
    Diab Vasc Dis Res; 2010 Oct; 7(4):251-9. PubMed ID: 20921090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of adiposity to subclinical atherosclerosis in obese patients with type 2 diabetes.
    Hegazi RA; Sutton-Tyrrell K; Evans RW; Kuller LH; Belle S; Yamamoto M; Edmundowicz D; Kelley DE
    Obes Res; 2003 Dec; 11(12):1597-605. PubMed ID: 14694226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of insulin to improve glycemic control in diabetes mellitus.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Cardiovasc Drugs Ther; 2008 Jun; 22(3):241-51. PubMed ID: 18347965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenesis and atherothrombosis--focus on diabetes mellitus.
    Stratmann B; Tschoepe D
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):291-303. PubMed ID: 19520304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Procoagulant membranous microparticles and atherothrombotic complications in diabetics].
    Morel O; Hugel B; Jesel L; Zobairi F; Bareiss P; Freyssinet JM; Toti F
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1006-12. PubMed ID: 16008179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms linking diabetes to the accelerated development of atherosclerosis.
    Zeadin MG; Petlura CI; Werstuck GH
    Can J Diabetes; 2013 Oct; 37(5):345-50. PubMed ID: 24500563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.